Fund moves

Kura Oncology (KURA): Siren, L.L.C. exited its position 1.34M shares

Siren, L.L.C. exited its position in Kura Oncology, per its Q1 2025 13F.

1.34M
Prior-quarter shares · no longer reported
Holdings as of
Mar 31, 2025
Filed
May 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 21, 2025InsiderDirector sold ~$181K of KURA shares in the open market
  2. May 19, 2025Insider · 2 peopleInsiders: 2 sales (~$19K)

What came next

  1. Aug 13, 2025InsiderCEO purchased ~$90K of KURA shares in the open market
  2. Sep 8, 2025InsiderCEO purchased ~$410K of KURA shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Kura Oncology

For Kura Oncology, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KURA page.

How this filing works

Explore the data

Common questions

What does this filing report about Kura Oncology (KURA) stock?

Siren, L.L.C. exited its position in Kura Oncology, per its Q1 2025 13F. Held the prior quarter, no longer listed per its Q1 2025 13F.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: May 23, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Kura Oncology recently?

For Kura Oncology, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the KURA page.

Does this mean KURA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Kura Oncology

Everything OQRO holds on this company is on its KURA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data